[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU4281385A - Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications - Google Patents

Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications

Info

Publication number
AU4281385A
AU4281385A AU42813/85A AU4281385A AU4281385A AU 4281385 A AU4281385 A AU 4281385A AU 42813/85 A AU42813/85 A AU 42813/85A AU 4281385 A AU4281385 A AU 4281385A AU 4281385 A AU4281385 A AU 4281385A
Authority
AU
Australia
Prior art keywords
foem
lymphokine
pure
applications
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU42813/85A
Other versions
AU592753B2 (en
Inventor
Gerd Burmeister
Clemens Sorg
Lajos Tarcsay
Walter Wiesendanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU4281385A publication Critical patent/AU4281385A/en
Application granted granted Critical
Publication of AU592753B2 publication Critical patent/AU592753B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

AU42813/85A 1984-05-24 1985-05-23 Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications Expired - Fee Related AU592753B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH2557/84 1984-05-24
CH255784 1984-05-24
CH378684 1984-08-07
CH3786/84 1984-08-07

Publications (2)

Publication Number Publication Date
AU4281385A true AU4281385A (en) 1985-11-28
AU592753B2 AU592753B2 (en) 1990-01-25

Family

ID=25690762

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42813/85A Expired - Fee Related AU592753B2 (en) 1984-05-24 1985-05-23 Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications

Country Status (1)

Country Link
AU (1) AU592753B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27304A1 (en) 2001-05-24 2002-12-31 Avanir Pharmaceuticals INHIBITORS OF THE INHIBITOR FACTOR OF MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
BRPI0413695A (en) 2003-08-22 2006-10-24 Avanir Pharmaceuticals substituted naphthyridine derivatives as inhibitors of macrophage migration inhibiting factor and its use in the treatment of human disease
WO2006102191A1 (en) 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors

Also Published As

Publication number Publication date
AU592753B2 (en) 1990-01-25

Similar Documents

Publication Publication Date Title
EP0205405A3 (en) Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
AU555575B2 (en) Polypeptide preparation in vertebrate cell culture
AU4154385A (en) Antibodies, manufacture and use
DE3377363D1 (en) Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
EP0212403A3 (en) Monoclonal antibodies to mucin-like human differentiation antigens
IL70573A0 (en) Cell lines,their production and their use for producing proteins
IL88160A0 (en) Cell lines and monoclonal antibodies
AU616156B2 (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
EP0174204A3 (en) Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof
AU6373286A (en) Auto-anti-idiotypic monoclonal antibodies to steroid receptals and uses thereof
AU3912385A (en) Cryogenic cell
GB8431152D0 (en) Lymphokine monoclonal antibody
IL83291A0 (en) Monoclonal antibody against ovarian cancer cells(ovb-3)
AU592753B2 (en) Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications
AU4970885A (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
AU7913887A (en) Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor
DE3561242D1 (en) Peroxycarbonate group-containing copolymer and method for manufacture thereof
ZA853915B (en) Lymphokine in pure form,novel monoclonal antibodies,hybridoma cell lines,processes and applications
AU582416B2 (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
AU7165891A (en) Tumor-specific, cell surface-binding monoclonal antibodies
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU3617984A (en) Cell line and monoclonal antibody
IL86678A0 (en) Hybrid cell line and monoclonal antibodies
IL78871A0 (en) Monoclonal antibodies,hybridoma cell lines and their preparation